Phenominer Database Results (88 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Experiment Notes Record ID Study ID
BN/Crl plasma glucose level fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood glucose amount male 168 days 20 88.2 mg/dl 3.6 16.1 intravenous glucose tolerance test 0.0 0 plasma glucose analysis 0.8 g glucose/kg 67318 66
BN/Crl plasma insulin level fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood insulin amount male 84 days 15 7.19 mU/l 1.01 3.9 intravenous glucose tolerance test 0.0 0 plasma insulin analysis 67327 66
BN/Crl plasma high density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood HDL cholesterol amount male 84 days 23 27.41 mg/dl 1.16 5.56 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 67351 66
BN/Crl plasma high density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood HDL cholesterol amount female 168 days 11 31.27 mg/dl 1.16 3.84 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 67360 66
BN/Crl plasma low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood LDL cholesterol amount female 84 days 18 8.88 mg/dl 0.39 1.64 plasma low-density lipoprotein-cholesterol measurement test 0.0 0 67369 66
BN/Crl plasma phospholipid level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood phospholipid amount male 84 days 20 1.14 mmol/l 0.04 0.18 plasma phospholipid analysis 0.0 0 plasma phospholipid analysis/test plasma phospholipid 67399 66
BN/Crl body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass female 84 days 33 160.0 g 2.0 11.49 body weighing method 0 11295 66
BN/Crl plasma very low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood VLDL cholesterol amount male 84 days 22 TC - (HDL-C and LDL-C) = VLDL-C 20.85 mg/dl 1.54 7.24 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 calculated vldl cholesterol 67375 66
BN/Crl plasma triglyceride level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood triglyceride amount male 168 days 19 0.7 mmol/l 0.03 0.13 plasma triglyceride analysis 0.0 0 67390 66
BN/Crl plasma total cholesterol level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood cholesterol amount male 90 days 29 61.78 mg/dl 1.16 6.24 automated blood analysis 0.0 0 67895 69
BN/Crl plasma insulin-like growth factor 1 level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood insulin-like growth factor amount female 60 days 6 665.0 ng/ml 48.0 117.58 enzyme linked immunosorbent assay 0.0 0 68785 1012
BN/Crl plasma corticosterone level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood corticosterone amount female 60 days 6 441.0 ng/ml 67.0 164.12 enzyme linked immunosorbent assay 0.0 0 68789 1012
BN/Crl calculated total pancreatic islet beta cell weight fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait male 60 days 6 5.39 mg 0.3 0.73 ex vivo light microscopy with digital image analysis 0.0 0 68764 1012
BN/Crl body weight fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. body mass male 60 days 6 191.0 g 4.0 9.8 body weighing method 0.0 0 68768 1012
BN/Crl plasma insulin level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood insulin amount female 60 days 6 6.06 mU/l 0.81 1.97 enzyme linked immunosorbent assay 0.0 0 68777 1012
BN/Crl ratio of insulin-positive cell area to total area of duodenal region of pancreas fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait male 60 days 6 0.67 % 0.07 0.17 ex vivo light microscopy with digital image analysis 0.0 0 ratio of duodenal IPCA 68748 1012
BN/Crl plasma low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood LDL cholesterol amount female 90 days 20 8.49 mg/dl 0.39 1.73 automated blood analysis 0.0 0 68456 69
BN/Crl water intake drink rate to body weight ratio arterial catheter implantation (for 1 days) Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. drinking behavior trait male 89 days-95 days 10 0.6 ml/d/kg 0.1 0.32 drink intake measuring method 0.0 arterial catheter implantation 1 days Water consumed (g) postsurgery per 100 g BW 107164 3077
BN/Crl hematocrit arterial catheter implantation (for 1 days) then controlled hemorrhage (for 0.4 hours) Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. erythrocyte quantity male 89 days-95 days 10 30.9 % 1.1 3.48 microhematocrit tube assay with visual assessment 0.0 0 initial hematocrit, final hematocrit, change in hematocrit 107259 3077
BN/Crl plasma total cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood cholesterol amount male 168 days 20 62.93 mg/dl 1.93 8.63 plasma total cholesterol measurement test 0.0 0 67342 66
BN/Crl plasma total cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood cholesterol amount male 84 days 23 62.55 mg/dl 1.54 7.41 plasma total cholesterol measurement test 0.0 0 67339 66
BN/Crl plasma insulin level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood insulin amount male 60 days 6 6.4 mU/l 1.12 2.74 enzyme linked immunosorbent assay 0.0 0 68776 1012
BN/Crl plasma glucose level fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood glucose amount female 168 days 11 99.0 mg/dl 5.4 17.91 intravenous glucose tolerance test 0.0 0 0.8 g glucose/kg 67324 66
BN/Crl plasma insulin level fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood insulin amount male 168 days 20 5.47 mU/l 0.72 3.22 intravenous glucose tolerance test 0.0 0 plasma insulin analysis 67330 66
BN/Crl plasma low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood LDL cholesterol amount male 168 days 20 11.97 mg/dl 0.77 3.45 plasma low-density lipoprotein-cholesterol measurement test 0.0 0 67366 66
BN/Crl plasma free fatty acids level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood free fatty acid amount male 168 days 20 1.26 mmol/l 0.07 0.31 plasma free fatty acid analysis 0.0 0 plasma phospholipid plasma phospholipid 67420 66
BN/Crl body weight control condition Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. body mass male 90 days 28 236.0 g 5.0 26.46 body weighing method 0 11298 69
BN/Crl body weight control condition Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. body mass female 90 days 36 159.0 g 2.0 12.0 body weighing method 0 11303 69
BN/Crl plasma triglyceride level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood triglyceride amount female 84 days 17 0.88 mmol/l 0.04 0.16 plasma triglyceride analysis 0.0 0 67393 66
BN/Crl plasma insulin-like growth factor 1 level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood insulin-like growth factor amount male 60 days 6 846.0 ng/ml 288.0 705.45 enzyme linked immunosorbent assay 0.0 0 68784 1012
BN/Crl duodenal region pancreatic beta cell weight calculated as the product of pancreas duodenal region weight and corresponding beta cell fractional area fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait female 60 days 6 1.38 mg 0.1 0.24 ex vivo light microscopy with digital image analysis 0.0 0 68757 1012
BN/Crl splenic region pancreatic beta cell weight calculated as the product of pancreas splenic region weight and corresponding beta cell fractional area fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait male 60 days 6 3.75 mg 0.28 0.69 ex vivo light microscopy with digital image analysis 0.0 0 68760 1012
BN/Crl body weight fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. body mass female 60 days 6 155.0 g 6.0 14.7 body weighing method 0.0 0 68769 1012
BN/Crl plasma glucose level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood glucose amount female 60 days 6 129.96 mg/dl 3.96 9.7 automated blood analysis 0.0 0 automated plasma glucose analysis mM 68773 1012
BN/Crl plasma triglyceride level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood triglyceride amount female 90 days 17 0.88 mmol/l 0.04 0.16 automated blood analysis 0.0 0 68426 69
BN/Crl plasma low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood LDL cholesterol amount male 90 days 26 15.44 mg/dl 1.16 5.91 automated blood analysis 0.0 0 68451 69
BN/Crl food intake weight to body weight ratio arterial catheter implantation (for 1 days) Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. eating behavior trait male 89 days-95 days 10 5.5 g/d/100g 0.3 0.95 food intake measuring method 0.0 arterial catheter implantation 1 days Food consumed (g) postsurgery per 100 g BW 107148 3077
BN/Crl mean arterial blood pressure arterial catheter implantation (for 1 days) Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. arterial blood pressure trait male 89 days-95 days 10 120.0 mmHg 3.0 9.49 vascular fluid filled catheter 300.0 0 5-second intervals Initial MAP 107339 3077
BN/Crl plasma high density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood HDL cholesterol amount male 168 days 20 29.73 mg/dl 0.77 3.45 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 67354 66
BN/Crl volume of blood removed to total prehemorrhagic blood volume ratio arterial catheter implantation (for 1 days) then controlled hemorrhage (for 0.4 hours) Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. blood amount male 89 days-95 days 10 5.83 mL/100 g of body weight 56.5 % 0.6 1.9 body weighing method 0 volume of blood removed to total prehemorrhagic blood volume ratio (CMO:0003663) 109133 3077
BN/Crl plasma phospholipid level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood phospholipid amount male 90 days 20 1.14 mmol/l 0.04 0.18 automated blood analysis 0.0 0 68431 69
BN/Crl plasma total cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood cholesterol amount female 168 days 11 62.16 mg/dl 1.16 3.84 plasma total cholesterol measurement test 0.0 0 67348 66
BN/Crl plasma low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood LDL cholesterol amount male 84 days 22 15.06 mg/dl 1.16 5.43 plasma low-density lipoprotein-cholesterol measurement test 0.0 0 67363 66
BN/Crl plasma low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood LDL cholesterol amount female 168 days 11 5.79 mg/dl 0.39 1.28 plasma low-density lipoprotein-cholesterol measurement test 0.0 0 67372 66
BN/Crl plasma phospholipid level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood phospholipid amount male 168 days 16 1.22 mmol/l 0.03 0.12 plasma phospholipid analysis 0.0 0 plasma phospholipid plasma phospholipid 67403 66
BN/Crl plasma free fatty acids level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood free fatty acid amount female 84 days 10 1.41 mmol/l 0.11 0.35 plasma free fatty acid analysis 0.0 0 plasma phospholipid plasma phospholipid 67423 66
BN/Crl plasma very low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood VLDL cholesterol amount female 84 days 18 TC - (HDL-C and LDL-C) = VLDL-C 25.48 mg/dl 1.16 4.91 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 calculated vldl cholesterol 67381 66
BN/Crl plasma corticosterone level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood corticosterone amount male 60 days 6 283.0 ng/ml 30.0 73.48 enzyme linked immunosorbent assay 0.0 0 68788 1012
BN/Crl plasma prolactin level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood prolactin amount male 60 days 6 36.0 ng/ml 5.0 12.25 enzyme linked immunosorbent assay 0.0 0 68792 1012
BN/Crl duodenal region pancreatic beta cell weight calculated as the product of pancreas duodenal region weight and corresponding beta cell fractional area fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait male 60 days 6 1.7 mg 0.12 0.29 ex vivo light microscopy with digital image analysis 0.0 0 68756 1012
BN/Crl splenic region pancreatic beta cell weight calculated as the product of pancreas splenic region weight and corresponding beta cell fractional area fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait female 60 days 6 3.59 mg 0.21 0.51 ex vivo light microscopy with digital image analysis 0.0 0 68761 1012
BN/Crl calculated total pancreatic islet beta cell weight fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait female 60 days 6 4.9 mg 0.19 0.47 ex vivo light microscopy with digital image analysis 0.0 0 68765 1012
BN/Crl plasma growth hormone level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood growth hormone amount female 60 days 6 101.0 ng/ml 5.0 12.25 enzyme linked immunosorbent assay 0.0 0 68781 1012
BN/Crl plasma growth hormone level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood growth hormone amount male 60 days 6 59.0 ng/ml 10.0 24.49 enzyme linked immunosorbent assay 0.0 0 68780 1012
BN/Crl plasma high density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood HDL cholesterol amount female 90 days 22 32.43 mg/dl 0.77 3.62 automated blood analysis 0.0 0 68446 69
BN/Crl plasma very low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood VLDL cholesterol amount female 90 days 20 TC-(HDL-C + LDL-C)=VLDL-C 24.71 mg/dl 1.16 5.18 automated blood analysis 0.0 0 68466 69
BN/Crl hematocrit arterial catheter implantation (for 1 days) then controlled hemorrhage (for 0 hours) Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. erythrocyte quantity male 89 days-95 days 10 41.8 % 1.3 4.11 microhematocrit tube assay with visual assessment 0.0 0 initial hematocrit, final hematocrit, change in hematocrit 107243 3077
BN/Crl body weight control condition Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. body mass male 88 days-94 days 10 259.0 g 6.0 18.97 body weighing method 0.0 0 107346 3077
BN/Crl plasma high density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood HDL cholesterol amount female 84 days 18 32.05 mg/dl 1.16 4.91 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 67357 66
BN/Crl plasma glucose level fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood glucose amount male 84 days 23 93.6 mg/dl 1.8 8.63 intravenous glucose tolerance test 0.0 0 plasma glucose analysis 0.8 g glucose/kg 67315 66
BN/Crl ratio of insulin-positive cell area to total area of splenic region of pancreas fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait male 60 days 6 0.75 % 0.13 0.32 ex vivo light microscopy with digital image analysis 0.0 0 68752 1012
BN/Crl plasma insulin level fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood insulin amount female 168 days 10 7.05 mU/l 1.44 4.55 intravenous glucose tolerance test 0.0 0 plasma insulin analysis 67336 66
BN/Crl body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass male 168 days 15 313.0 g 4.0 15.49 body weighing method 0 11292 66
BN/Crl body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass male 84 days 26 237.0 g 5.0 25.5 body weighing method 0 11289 66
BN/Crl plasma very low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood VLDL cholesterol amount male 90 days 23 TC-(HDL-C + LDL-C)=VLDL-C 20.46 mg/dl 1.16 5.56 automated blood analysis 0.0 0 68461 69
BN/Crl plasma phospholipid level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood phospholipid amount female 168 days 8 1.38 mmol/l 0.03 0.08 plasma phospholipid analysis 0.0 0 plasma phospholipid plasma phospholipid 67411 66
BN/Crl plasma prolactin level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood prolactin amount female 60 days 6 113.0 ng/ml 17.0 41.64 enzyme linked immunosorbent assay 0.0 0 68793 1012
BN/Crl body weight control condition Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 body mass female 168 days 23 200.0 g 5.0 23.98 body weighing method 0.0 0 67312 66
BN/Crl plasma insulin level fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood insulin amount female 84 days 12 4.32 mU/l 0.43 1.5 intravenous glucose tolerance test 0.0 0 plasma insulin analysis 67333 66
BN/Crl plasma free fatty acids level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood free fatty acid amount male 84 days 13 1.16 mmol/l 0.08 0.29 plasma free fatty acid analysis 0.0 0 plasma phospholipid plasma phospholipid 67417 66
BN/Crl plasma free fatty acids level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood free fatty acid amount female 168 days 10 1.15 mmol/l 0.07 0.22 plasma free fatty acid analysis 0.0 0 plasma phospholipid plasma phospholipid 67426 66
BN/Crl systolic blood pressure control condition Viel EC, et al., Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H938-44. Epub 2009 Dec 31. arterial blood pressure trait male 84 days 12 113.0 mmHg 5.0 17.32 tail cuff plethysmography 0.0 0 67227 730
BN/Crl plasma very low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood VLDL cholesterol amount male 168 days 20 TC - (HDL-C and LDL-C) = VLDL-C 21.24 mg/dl 1.54 6.91 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 calculated vldl cholesterol 67378 66
BN/Crl plasma very low density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood VLDL cholesterol amount female 168 days 11 TC - (HDL-C and LDL-C) = VLDL-C 24.71 mg/dl 1.54 5.12 plasma high-density lipoprotein-cholesterol measurement test 0.0 0 calculated vldl cholesterol 67384 66
BN/Crl plasma triglyceride level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood triglyceride amount male 84 days 22 0.79 mmol/l 0.03 0.14 plasma triglyceride analysis 0.0 0 67387 66
BN/Crl plasma glucose level fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. blood glucose amount male 60 days 6 127.8 mg/dl 3.06 7.5 automated blood analysis 0.0 0 mM 68772 1012
BN/Crl ratio of insulin-positive cell area to total area of splenic region of pancreas fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait female 60 days 6 0.8 % 0.1 0.24 ex vivo light microscopy with digital image analysis 0.0 0 68753 1012
BN/Crl ratio of insulin-positive cell area to total area of duodenal region of pancreas fasting (between 16 and 18 hours) Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. pancreatic beta cell morphology trait female 60 days 6 0.56 % 0.12 0.29 ex vivo light microscopy with digital image analysis 0.0 0 ratio of duodenal IPCA 68749 1012
BN/Crl plasma total cholesterol level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood cholesterol amount female 90 days 18 66.41 mg/dl 1.93 8.19 automated blood analysis 0.0 0 68416 69
BN/Crl plasma triglyceride level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood triglyceride amount male 90 days 22 0.79 mmol/l 0.03 0.14 automated blood analysis 0.0 0 68421 69
BN/Crl plasma high density lipoprotein cholesterol level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood HDL cholesterol amount male 90 days 26 27.03 mg/dl 0.77 3.94 automated blood analysis 0.0 0 68441 69
BN/Crl absolute change in hematocrit arterial catheter implantation (for 1 days) then controlled hemorrhage (between 0 and 0.4 hours) Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. erythrocyte quantity male 89 days-95 days 10 10.7 % 1.0 3.16 microhematocrit tube assay with visual assessment 0.0 0 initial hematocrit, final hematocrit, change in hematocrit 107275 3077
BN/Crl maximum body weight loss to initial body weight ratio arterial catheter implantation (for 1 days) Klemcke HG, etal., Shock. 2008 Jun;29(6):748-53. body mass male 89 days-95 days 10 3.6 % 0.7 2.21 body weighing method 0.0 arterial catheter implantation 1 days 107185 3077
BN/Crl plasma glucose level fasting (between 16 and 18 hours) then glucose solution (0.8 g/kg) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood glucose amount female 84 days 18 102.6 mg/dl 3.6 15.27 intravenous glucose tolerance test 0.0 0 0.8 g glucose/kg 67321 66
BN/Crl plasma total cholesterol level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood cholesterol amount female 84 days 18 66.41 mg/dl 1.93 8.19 plasma total cholesterol measurement test 0.0 0 67345 66
BN/Crl plasma phospholipid level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood phospholipid amount female 84 days 15 1.44 mmol/l 0.05 0.19 plasma phospholipid analysis 0.0 0 plasma phospholipid plasma phospholipid 67406 66
BN/Crl plasma phospholipid level fasting (between 16 and 18 hours) Wallace KJ, et al., Physiol Genomics 2004 Sep 16;19(1):1-10. Epub 2004 Jul 20. blood phospholipid amount female 90 days 15 1.44 mmol/l 0.05 0.19 automated blood analysis 0.0 0 68436 69
BN/Crl plasma triglyceride level fasting (between 16 and 18 hours) Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26 blood triglyceride amount female 168 days 10 0.87 mmol/l 0.05 0.16 plasma triglyceride analysis 0.0 0 67396 66